The Four Claim Types to Verify First
Every promoted program makes four kinds of claim: a product you must buy, a prescription route, an outcome promise, and authority borrowed from someone else. Check them in that order, because each is harder to unwind after payment. Open the ad or landing page that brought you here and read it against each type.
Why Diabetes Offers Carry So Many Claims
A recent lab result, a family history, a sponsored search result, and a card request before you speak to a human: that is the sequence. A chronic-condition audience plus money pulls hard toward promising a cure. Google's publisher policies mark where that pull goes wrong: they bar ads on content promoting harmful health claims, facilitating online prescription-drug sales, or promoting unapproved drugs and supplements. Those limits show what the ad market treats as unsafe selling — a caution signal, not proof that a compliant program works.
Claim Type 1: A Product Bundled Into the Program
What it looks like: the fee covers a supplement, a "natural" formula or a starter kit, or an upsell appears right after sign-up, with ingredient claims about blood sugar. Google restricts monetising content that promotes unapproved drugs and supplements, naming herbal supplements with active pharmaceutical or dangerous ingredients and products named confusingly like approved drugs, and links a non-exhaustive list that was not retrieved here, so no bottle can be labelled as on it. The question to ask: is any part of this program a product I must buy, and exactly what is in it?
Claim Type 2: Prescriptions Sold or Routed Online
The pattern is "no visit needed, medication shipped." Google's publisher policy makes content that facilitates online prescription-drug sales a restricted category, citing selling prescription drugs and online pharmacies. The practical check is not whether the page looks medical; it is who writes the prescription, who dispenses it, and whether your own clinician will see the record. A questionnaire followed by a fulfilment partner you cannot name is an unresolved answer, not a reassuring one.
Claim Type 3: Cure, Guarantee and Urgency Language
Watch for "reverse diabetes in 30 days," "drug-free," "guaranteed results," and countdown timers. Then run the substitution test: does the page pair a named measure with a named source and a date, or offer adjectives and "studies show"? Google bars ads on content promoting harmful health claims, including content that contradicts authoritative scientific consensus in a major health crisis. That is a policy limit, not a verdict on any program. This article cannot validate any outcome figure, so treat "cures," "reverses," "clinically proven" and agency-endorsement wording as unverified marketing.
Claim Type 4: Borrowed Authority and Nameless Experts
Authority gets borrowed rather than shown: agency logos, clinician badges, review stars, a "list of top doctors near you" that never appears, no named operator, nobody named as clinically responsible. Google's misrepresentation policy bars content that misstates the publisher, creator or purpose, or implies an affiliation or endorsement that does not exist, and its examples treat a "top doctors" promise never delivered as a disallowed behaviour. Two lookups matter most: who owns the site, and who is named as clinically responsible.
What the Ad Categories Cover, and What They Do Not
The table maps three offer types onto what the retrieved policy documents actually say. The third row is a deliberate gap, not an estimate.
| Offer type | What the retrieved policy says | Source and verification status |
|---|
| Bundles or upsells a supplement | Unapproved drugs and supplements may not be promoted, including herbal products with pharmaceutical or dangerous ingredients | support.google.com/publisherpolicies/answer/10437888 — documented; linked list not retrieved |
| Sells or routes prescription medication online | Facilitating online prescription-drug sales is a restricted category; online pharmacies are named as an example | support.google.com/publisherpolicies/answer/10437489 — documented at category level |
| Coaching or education selling no drug or supplement | No retrieved policy text addresses this format | Undocumented — a stated gap, not an estimate |
The first two rows are why product and prescription questions come first: those categories are documented. The third row is silence, and silence in a policy document says nothing about quality or safety.
The Five-Minute Checklist That Replaces the Ad
Ask these six questions before entering a card number. A usable reply is specific and written down.
- Who operates this? A named company, a real address, a reachable person.
- Who runs the sessions, with what training? A checkable role and organisation.
- What happens when the program ends? A described next step.
- What is the total cost, and is coverage confirmed in writing? An email or PDF beats a spoken "insurance takes care of it."
- Will my own clinician be contacted or informed? Explicit consent to share records.
- What data is gathered, and is it used for marketing? Health information is treated as sensitive under Google's personalised-advertising rules, so expect a specific answer.
If an answer arrives only by phone, ask for it in writing.
Where Marketing Ends and Clinical Decisions Begin
Whether a program suits a particular person, whether medication should change, and what targets are appropriate are clinical decisions for that person's clinician. No landing page, and no advertising-policy compliance, replaces that conversation.
What This Guide Does Not Establish
The evidence base here is Google publisher and advertising policy documents only. No clinical guideline, federal program page, payer coverage page or program-level source was retrieved, so no prevalence statistic, A1c threshold, session count, duration, price or coverage rule is asserted. Policy wording is paraphrased from a Chinese-language rendering retrieved for this task; re-check current English wording before quoting. Scope is US-only, and variation by plan and state is unknown. Corrections are welcome.
研究の知恵